Literature DB >> 28719495

Late-Onset Hiv Encephalopathy In Children With Long-Standing Virologic Suppression Followed By Slow Spontaneous Recovery Despite no Change In Antiretroviral Therapy: 4 Case Reports.

Steve Innes1, Ronald van Toorn, Kennedy Otwombe, Els Dobbels, Gert van Zyl, Mark F Cotton, Barbara Laughton.   

Abstract

We describe 4 Children with HIV Early Antiretroviral Therapy trial participants with late-onset HIV encephalopathy despite long-standing viral suppression in blood and undetectable HIV DNA and RNA polymerase chain reaction in cerebrospinal fluid. Extensive investigations revealed no alternative etiology. Reassuringly, all 4 experienced slow spontaneous recovery despite no change in antiretroviral therapy. Virally suppressed HIV-infected children remain at risk for fluctuating neurologic signs and symptoms.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28719495      PMCID: PMC5638699          DOI: 10.1097/INF.0000000000001694

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   3.806


  10 in total

1.  Impact of the HIV Tat C30C31S dicysteine substitution on neuropsychological function in patients with clade C disease.

Authors:  Robert H Paul; John A Joska; Carol Woods; Soraya Seedat; Susan Engelbrecht; Jacqueline Hoare; Jodi Heaps; Victor Valcour; Beau Ances; Laurie M Baker; Lauren E Salminen; Dan J Stein
Journal:  J Neurovirol       Date:  2014-11-01       Impact factor: 2.643

2.  Brain mitochondrial injury in human immunodeficiency virus-seropositive (HIV+) individuals taking nucleoside reverse transcriptase inhibitors.

Authors:  Brian C Schweinsburg; Michael J Taylor; Omar M Alhassoon; Raul Gonzalez; Gregory G Brown; Ronald J Ellis; Scott Letendre; John S Videen; J Allen McCutchan; Thomas L Patterson; Igor Grant
Journal:  J Neurovirol       Date:  2005-08       Impact factor: 2.643

3.  HIV-1 viral escape in cerebrospinal fluid of subjects on suppressive antiretroviral treatment.

Authors:  Arvid Edén; Dietmar Fuchs; Lars Hagberg; Staffan Nilsson; Serena Spudich; Bo Svennerholm; Richard W Price; Magnus Gisslén
Journal:  J Infect Dis       Date:  2010-11-04       Impact factor: 5.226

4.  Neurocognitive effects of treatment interruption in stable HIV-positive patients in an observational cohort.

Authors:  K R Robertson; Z Su; D M Margolis; A Krambrink; D V Havlir; S Evans; D J Skiest
Journal:  Neurology       Date:  2010-03-17       Impact factor: 9.910

5.  Salvage therapy with abacavir and other reverse transcriptase inhibitors for human immunodeficiency-associated encephalopathy.

Authors:  Jesús Saavedra-Lozano; José T Ramos; Francisco Sanz; M Luisa Navarro; M I de José; P Martín-Fontelos; María J Mellado; Juan A León Leal; Cecilia Rodriguez; Isabel Luque; Samuel J Madison; David Irlbeck; E Randall Lanier; Octavio Ramilo
Journal:  Pediatr Infect Dis J       Date:  2006-12       Impact factor: 2.129

6.  Cerebrospinal fluid HIV RNA originates from both local CNS and systemic sources.

Authors:  R J Ellis; A C Gamst; E Capparelli; S A Spector; K Hsia; T Wolfson; I Abramson; I Grant; J A McCutchan
Journal:  Neurology       Date:  2000-02-22       Impact factor: 9.910

7.  Neurovirological correlation with HIV-associated neurocognitive disorders and encephalitis in a HAART-era cohort.

Authors:  Benjamin B Gelman; Joshua G Lisinicchia; Susan Morgello; Eliezer Masliah; Deborah Commins; Cristian L Achim; Howard S Fox; Dennis L Kolson; Igor Grant; Elyse Singer; Constantin T Yiannoutsos; Seth Sherman; Gary Gensler; David J Moore; Tiansheng Chen; Vicki M Soukup
Journal:  J Acquir Immune Defic Syndr       Date:  2013-04-15       Impact factor: 3.731

8.  Cognitive decline with immunologic and virologic stability in four children with human immunodeficiency virus disease.

Authors:  Mary Anne Toledo Tamula; Pamela L Wolters; Claire Walsek; Steven Zeichner; Lucy Civitello
Journal:  Pediatrics       Date:  2003-09       Impact factor: 7.124

9.  Early time-limited antiretroviral therapy versus deferred therapy in South African infants infected with HIV: results from the children with HIV early antiretroviral (CHER) randomised trial.

Authors:  Mark F Cotton; Avy Violari; Kennedy Otwombe; Ravindre Panchia; Els Dobbels; Helena Rabie; Deirdre Josipovic; Afaaf Liberty; Erica Lazarus; Steve Innes; Anita Janse van Rensburg; Wilma Pelser; Handre Truter; Shabir A Madhi; Edward Handelsman; Patrick Jean-Philippe; James A McIntyre; Diana M Gibb; Abdel G Babiker
Journal:  Lancet       Date:  2013-11-09       Impact factor: 79.321

10.  HIV Encephalopathy: pediatric case series description and insights from the clinic coalface.

Authors:  Kirsten A Donald; Kathleen G Walker; Tracy Kilborn; Henri Carrara; Nelleke G Langerak; Brian Eley; Jo M Wilmshurst
Journal:  AIDS Res Ther       Date:  2015-01-17       Impact factor: 2.250

  10 in total
  1 in total

1.  Propelling the Pediatric HIV Therapeutic Agenda With Science, Innovation, and Collaboration.

Authors:  Elaine J Abrams; Jintanat Ananworanich; Moherndran Archary; McNeil Ngongondo; Pim Brouwers
Journal:  J Acquir Immune Defic Syndr       Date:  2018-08-15       Impact factor: 3.731

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.